Sector Spotlight: Medical Device Professional Services

A Growing Market & M&A Opportunity

For decades, pharmaceutical companies have experienced rising pressures on their business models, causing a heavier reliance on outsourced providers to better manage their key operations. While the outsourced pharma services sector is well established, the same outsourcing shift is just beginning in medical devices.

Now facing similar industry challenges like greater product development and regulatory complexity, medical device manufacturers are rapidly turning to experts in design and engineering, regulatory affairs, clinical trials, and commercialization.

These professional services are becoming increasingly essential and growing quickly as medical device manufacturers focus on core competencies and establish efficiencies across their value chains. This presents tremendous value-creation opportunities for investors ready to capitalize on this outsourcing trend and get in early on the market’s growth curve.

RQM+ and Jordi Labs: Exemplars in the Space

As an example of this value-creation strategy, Harris Williams clients RQM+ and Jordi Labs recently joined forces to offer customers more comprehensive solutions.

RQM+, a regulatory and quality consulting business, acquired Jordi Labs, which specializes in analytical chemistry testing required by regulatory bodies such as the FDA. Both companies have benefited greatly from rising medical device regulatory scrutiny, but have also been limited to their respective niches.

Together, they now offer a comprehensive outsourced solution for all their clients’ regulatory needs, managing every aspect of a medical device’s required filings and tests to get it approved more easily, efficiently, and cost-effectively.

By combining their complementary services into an integrated offering, RQM+ and Jordi Labs can do more for their clients while generating additional growth and value in the process.